### Comment:
The paper shows that sotogliflozin resulted in 3% of patients experiencing DKA (while placebo was 0.6%). Also, the paper seems to show an increase in DKA (and other AEIs) when the patient uses an insulin pump. Is this comparable to the prior mentioned other/current treatments?

### REPLY:
Is this good? Calls or puts?

### END.